<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Posterior reversible <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> syndrome (PRES) is an uncommon but distinctive clinical-radiologic entity characterized by <z:hpo ids='HP_0002315'>headache</z:hpo>, <z:hpo ids='HP_0001250'>seizures</z:hpo>, visual disturbance, and altered mental function associated with reversible white matter <z:hpo ids='HP_0000969'>edema</z:hpo> affecting the posterior parietal and occipital lobes of the brain </plain></SENT>
<SENT sid="1" pm="."><plain>Although PRES is caused by a variety of conditions, <z:hpo ids='HP_0011009'>acute</z:hpo> elevation of blood pressure, fluid retention, and treatment with immunosuppressive drugs and/or anti-neoplastic agents are the main causes </plain></SENT>
<SENT sid="2" pm="."><plain>A few cases of PRES associated with hematopoietic stem cell transplantation (HSCT) in children have been reported </plain></SENT>
<SENT sid="3" pm="."><plain>Early recognition of PRES and appropriate management are needed to reduce the risk of permanent neurologic disability </plain></SENT>
<SENT sid="4" pm="."><plain>The authors report a case of PRES in a girl who received an HLA-identical sibling bone marrow transplantation for <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> to emphasize the importance of early recognition and institution of appropriate management of PRES during HSCT </plain></SENT>
</text></document>